Calidi Biotherapeutics, Inc.
CLDI· NYSE
CLDICalidi Biotherapeutics, Inc.
Filed Mar 15, 2024 · 10-K · 75 days after period end · 0001493152-24-010158
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | -$8.23M | -$7.76M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 15, 2024 · 75 d after period end
